Donald J. Kyle - Concepedia

Author

Donald J. Kyle

Purdue Pharma (United States)

Also Known As

D J Kyle, D. J. KYLE, D. J. Kyle, D.J. Kyle, Donald J Kyle, Donald J. Kyle, Donald Kyle

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Purdue Pharma (United States)Nova Research Company (United States)Purdue Pharma (Canada)Universidade Federal de Santa Catarina Freeport-McMoRan (United States)

About

Donald J. Kyle is an author at Purdue Pharma (United States) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	741
2	Biochemistry	11	11	404
3	Natural Sciences	10	10	391
4	Engineering	4	4	92
5	Health Sciences	3	3	89

Donald J. Kyle

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Stable Expression of the Human Kinin B1 Receptor in Chinese Hamster Ovary Cells Caroline E. Austin, H. Robinson, Sarvajit Chakravarty, Journal of Biological Chemistry	1997	123
Antinociceptive profile of the pseudopeptide B<sub>2</sub>bradykinin receptor antagonist NPC 18688 in mice Clovis R. Corrêa, Donald J. Kyle, Sarvajit Chakraverty, British Journal of Pharmacology	1996	107
Roles of μ-Opioid Receptors and Nociceptin/Orphanin FQ Peptide Receptors in Buprenorphine-Induced Physiological Responses in Primates Colette M Cremeans, Erin Gruley, Donald J. Kyle, Journal of Pharmacology and Experimental Therapeutics	2012	95
Design and conformational analysis of several highly potent bradykinin receptor antagonists Donald J. Kyle, Jennifer A. Martin, Stephen G. Farmer, Journal of Medicinal Chemistry Altmetric Attention ScorePeptide SciencePharmacotherapySystem PharmacologyPre-clinical Pharmacology	1991	85
Pharmacological profile of NPC 12626, a novel, competitive N-methyl-D-aspartate receptor antagonist. John W. Ferkany, Donald J. Kyle, Jonathon M. Willets, Journal of Pharmacology and Experimental Therapeutics	1989	78
A Proposed Model of Bradykinin Bound to the Rat B2 Receptor and Its Utility for Drug Design Donald J. Kyle, Sarvajit Chakravarty, Jacqueline A. Sinsko, Journal of Medicinal Chemistry	1994	77
Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides Donald J. Kyle, Jennifer A. Martin, Ronald M. Burch, Journal of Medicinal Chemistry Peptide EngineeringPeptide ScienceSystem PharmacologySystems PharmacologyMolecular Pharmacology	1991	68
NMR and computational evidence that high-affinity bradykinin receptor antagonists adopt C-terminal .beta.-turns Donald J. Kyle, Paul R. Blake, Damon Smithwick, Journal of Medicinal Chemistry Peptide EngineeringComputational EvidenceLinear TetrapeptidesMolecular PharmacologyMedicinal Chemistry	1993	57
Human B1 and B2 Bradykinin Receptors and Their Agonists Target Caveolae-Related Lipid Rafts to Different Degrees in HEK293 Cells Maria E. Lamb, Chongwu Zhang, Thomas Shea, Biochemistry	2002	55
Antioedematogenic and antinociceptive actions of NPC 18521, a novel bradykinin B2 receptor antagonist Rafael O.P. de Campos, Ricardo Vieira Alves, Donald J. Kyle, European Journal of Pharmacology Pain MedicineImmunologyPharmacologyNeuropeptide ReceptorMolecular Pain	1996	54

Page 1